Breast cancer staging for patients with “low‐risk” disease: Are they all the same?
Prognostic stage significantly influences survival among patients with low RS. RS < 11 alone should not automatically downstage patients to PPS IA; anatomic and other nongenomic factors remain important for prognosis.
Authors
- Ellery Reason (ORCID: https://orcid.org/0009-0004-0922-4446)
- Kelly Westbrook
- Maggie Lee DiNome (ORCID: https://orcid.org/0000-0002-1926-292X)
- Hannah E. Woriax (ORCID: https://orcid.org/0000-0002-8746-6457)
- Akiko Chiba
- Astrid Botty Van den Bruele
- Kendra J. Modell Parrish
- Tori C Nierenberg
- Samantha M. Thomas
- E. Shelley Hwang
- Jennifer K. Plichta
Institutions
- Duke University (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
- Duke Cancer Institute
Publication Details
- Journal
- Cancer
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1002/cncr.70305
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00